公司概述
Global Medical REIT Inc. operates within the Real Estate sector, specifically focusing on the REIT - Healthcare Facilities industry, where it acquires healthcare properties and leases them to physician groups and major healthcare systems under net-lease arrangements. The company employs a workforce of 26 individuals to manage its portfolio of medical facilities, serving as a specialized investment vehicle for investors seeking exposure to the healthcare real estate market. In terms of scale, the company holds a market capitalization of $979.78M and generates annual revenue of $144.83M, indicating a significant operational footprint within the niche medical real estate landscape. These valuation and revenue figures suggest that Global Medical REIT Inc. is a substantial entity capable of servicing a large debt load and maintaining extensive property operations, positioning it as a notable player despite its specialized industry focus.
财务健康
The company reported a revenue of $144.83M and an EBITDA of $87.53M over the trailing twelve months, while simultaneously recording a net income of -$3,324,000. The substantial gap between the positive EBITDA and the negative net income reveals a cost structure heavily influenced by significant interest expenses or non-operating costs that erode the bottom line despite strong operational cash generation. This financial profile is further supported by a free cash flow of $66.02M, which provides the company with considerable financial flexibility to service its obligations or pursue strategic initiatives without relying on external financing. Margins reflect this complex financial reality, with a gross margin of 99.9% indicating low direct costs of goods sold, an operating margin of 24.5% showing healthy operational efficiency, and a profit margin of 1.7% that is mathematically consistent with the reported net loss when scaled against total revenue. On the balance sheet, the company holds $14.59M in cash against total debt of $723.14M, resulting in a debt-to-equity ratio of 142.96, which characterizes a highly leveraged financial position rather than a conservative one. Liquidity is maintained at a current ratio of 1.91, suggesting the company possesses sufficient short-term assets to cover its current liabilities, though this buffer is narrow given the magnitude of its total debt obligations. Return on equity stands at 0.4% and return on assets is 1.7%, metrics that indicate management has faced challenges in generating substantial returns on the capital invested in the business, a common characteristic for REITs with heavy debt loads or those currently adjusting to market conditions.
估值评估
Valuation metrics for Global Medical REIT Inc. present a mixed picture, with a P/E ratio of N/A for the trailing twelve months and a forward P/E of 299.83. The discrepancy between the unavailable trailing P/E and the extremely high forward P/E implies that the market expects a significant turnaround in earnings or a re-rating of the stock to align with current price levels, rather than expecting immediate earnings normalization. The price-to-book ratio is 1.18, indicating that the market values the company at a slight premium over its net asset book value, suggesting confidence in the value of its underlying real estate portfolio. Alternative valuation multiples include a price-to-sales ratio of 6.77 and an EV/EBITDA of 14.70, which suggest the stock is priced at a premium relative to sales but remains reasonable relative to its earnings before interest, taxes, depreciation, and amortization when adjusted for enterprise value. The stock trades between a 52-week high of $45.75 and a 52-week low of $29.05, with the current price sitting significantly below the 52-week high, reflecting recent market volatility or a pullback from previous peaks. The beta of 1.20 indicates that the stock price is 20% more volatile than the broader market, meaning the asset is subject to higher fluctuations during periods of market stress compared to the average equity.
Growth & Income
Revenue growth stands at 8.6% year-over-year, while earnings growth is listed as N/A due to the negative net income, making a direct comparison of growth rates impossible in the traditional sense. The dividend yield is reported at 8.3%, which is notably high, but the payout ratio of 1114.3% indicates that the dividends paid exceed the reported net earnings, suggesting the company is funding payouts from cash reserves or debt proceeds rather than operating profits. Given the negative net income and the payout ratio exceeding 100%, the company's dividend sustainability relies on cash flow generation rather than earnings retention, and the high payout ratio is not sustainable if earnings do not turn positive quickly. The overall growth and income profile is characterized by strong top-line expansion coupled with a high-yield dividend that is currently disconnected from traditional earnings-based payout metrics.